bell
The current prices are delayed by 15 mins, login to check live prices.
Zim Laboratories Ltd share price logo

Zim Laboratories Ltd

(ZIMLAB)

₹109.80.08%

as on 04:01PM, 21 Oct 2024

Overview
News
Financials
Q2 2024 Results
Technicals

Zim Laboratories Ltd Performance

  • Day's Low

    Day's High

    ₹108.96
    ₹111.5
  • 52 Week's Low

    52 Week's High

    ₹89.5
    ₹131.4
1 Month Return+ 0.02 %
3 Month Return-1.07 %
1 Year Return-5.34 %
Previous Close₹109.71
Open₹110.61
Volume99.80K
Upper Circuit-
Lower Circuit-
Market Cap₹534.57Cr

Zim Laboratories Ltd Key Statistics

P/E Ratio29.89
PEG Ratio-91.52
Market Cap₹534.57 Cr
P/B Ratio2.01
EPS3.54
Dividend Yield0
SectorPharmaceuticals
ROE7.87

Zim Laboratories Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹534.57 Cr1.32%0.66₹17 Cr₹367 Cr
NA₹207.23 Cr49.33%0.79₹7 Cr₹339 Cr
NA₹10.56 Cr219.49%0.50NANA
BUY₹6,511.04 Cr14.02%0.62₹48 Cr₹717 Cr
NA₹28.64 Cr67.38%0.50NANA

About Zim Laboratories Ltd

Zim Laboratories Ltd is a publicly-listed major player in India's pharmaceutical industry, working in the fields of antibiotics, antibacterials, analgesics, and more. The company was incorporated in Maharashtra in 1998, and quickly began business production. While the industry is dominated by multinationals and large Indian companies, Zim Laboratories come in as a strong presence in the lower end of the market; primarily, small-scale industrial (SSI) sector. This company provides customers with a vast range of branded and generic drugs of the highest standards.

Share Price: ₹109.80 per share as on 21 Oct, 2024 04:01 PM
Market Capitalisation: ₹534.57Cr as of today
Revenue: ₹81.82Cr as on June 2024 (Q2 24)
Net Profit: ₹0.90Cr as on June 2024 (Q2 24)
Listing date: 25 Nov, 2022
Chairperson Name: Anwar S Daud
OrganisationZim Laboratories Ltd
Headquarters
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Zim Laboratories Ltd

  • Zim Laboratories Reports Decrease in Revenue and Net Income - 12 Jun, 2024

    Zim Laboratories reported a 7.8% decrease in revenue, with net income down by 29% and profit margin decreasing from 6.1% to 4.7% in FY 2024. EPS also decreased from ₹5.02 to ₹3.54. The Outside India segment contributed 78% of total revenue. Zim Laboratories shares are up 7.0% from a week ago.

  • ZIM Laboratories' Accrual Ratio Indicates Lower Free Cash Flow - 21 May, 2024

    An article suggests that ZIM Laboratories' free cash flow was significantly lower than its statutory profit, with a negative free cash flow of ₹576m over the last year. The company's earnings per share have grown impressively in the last three years, but investors are advised to analyze risks and warnings before investing.

  • ZIM Lab Reports Increase in Net Sales and Quarterly Net Profit - 17 May, 2024

    ZIM Lab's standalone net sales for March 2024 increased by 12.39% YoY, with a quarterly net profit of Rs. 7.89 crore, up 10.51% from the previous year. The company's EPS has also increased to Rs. 1.62 in March 2024. However, ZIM Lab shares have given negative returns of -5.65% over the last six months.

Insights on Zim Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 133.4% return, outperforming this stock by 147.0%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 33.26% of holdings in Jun 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 83.8% return, outperforming this stock by 89.1%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 8.09 Cr → 0.9 Cr (in ₹), with an average decrease of 88.9% per quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 66.73% to 66.63% in Jun 2024 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 year, ZIMLAB stock has moved down by -5.3%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 0.01% to 0.00% in Jun 2024 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 119.4 Cr → 82.82 Cr (in ₹), with an average decrease of 30.6% per quarter

Zim Laboratories Ltd Financials

Value in ₹ crore
DetailsQ'2 23Q'3 23Q'4 23Q'1 24Q'2 24
Revenue₹67.44Cr (-)₹85.83Cr (↑27.27%)₹96.29Cr (↑12.19%)₹117.86Cr (↑22.40%)₹81.82Cr (↓30.58%)
Net Income₹0.23Cr (-)₹4.15Cr (↑1,704.35%)₹4.78Cr (↑15.18%)₹8.09Cr (↑69.25%)₹0.90Cr (↓88.88%)
Net Profit Margin0.34% (-)4.84% (↑1,323.53%)4.96% (↑2.48%)6.86% (↑38.31%)1.10% (↓83.97%)
Value in ₹ crore
Details2021202220232024
Total Assets₹329.20Cr (-)₹344.58Cr (↑4.67%)₹339.09Cr (↓1.59%)₹443.72Cr (↑30.86%)
Total Liabilities₹172.15Cr (-)₹174.48Cr (↑1.35%)₹144.91Cr (↓16.95%)₹211.76Cr (↑46.13%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹21.29Cr (-)₹31.90Cr (↑49.84%)₹47.03Cr (↑47.43%)₹35.23Cr (↓25.09%)₹11.47Cr (↓67.44%)
0

Zim Laboratories Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
33.26%
0.00
Foreign Institutions
0%
-47.37
Mutual Funds
0%
0.00
Retail Investors
66.63%
-0.16
Others
0.11%
0.00

Zim Laboratories Ltd Key Indicators

Details20202021202220232024
Earning Per Share (₹)0.681.52.995.013.54
Details20202021202220232024
Return On Equity %1.155.847.9513.737.87
Details20202021202220232024
Return On Assets %0.992.224.227.23.89
Details20202021202220232024
Book Value Per Share (₹)31.6932.9936.0641.1249

Zim Laboratories Ltd Valuation

Zim Laboratories Ltd in the last 5 years

  • Overview

  • Trends

Lowest (6.12x)

June 11, 2018

Today (29.89x)

October 18, 2024

Industry (58.10x)

October 18, 2024

Highest (198.80x)

July 1, 2021

LowHigh

Zim Laboratories Ltd Earnings and Dividends

  • Zim Laboratories Ltd Earnings Results

    Zim Laboratories Ltd’s net profit jumped 291.3% since last year same period to ₹0.90Cr in the Q1 2024-2025. On a quarterly growth basis, Zim Laboratories Ltd has generated -88.88% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Zim Laboratories Ltd Dividends May,2019

    In the quarter ending March 2019, Zim Laboratories Ltd has declared dividend of ₹0.50 - translating a dividend yield of 1.37%.

    Read More about Dividends

Zim Laboratories Ltd Technicals Summary

Bearish

Neutral

Bullish

Bullish

Zim Laboratories Ltd is currently in a Bullish trading position according to technical analysis indicators.

FAQs on Zim Laboratories Ltd

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Zim Laboratories Ltd shares.

Zim Laboratories Ltd (ZIMLAB) share price today is ₹109.8

Zim Laboratories Ltd is listed on NSE

Zim Laboratories Ltd is listed on BSE

  • Today’s highest price of Zim Laboratories Ltd is ₹111.5.
  • Today’s lowest price of Zim Laboratories Ltd is ₹108.96.

PE Ratio of Zim Laboratories Ltd is 29.89

PE ratio = Zim Laboratories Ltd Market price per share / Zim Laboratories Ltd Earnings per share

Today’s traded volume of Zim Laboratories Ltd(ZIMLAB) is 99.80K.

Today’s market capitalisation of Zim Laboratories Ltd(ZIMLAB) is ₹534.57Cr.

Zim Laboratories Ltd(ZIMLABPrice
52 Week High
₹131.4
52 Week Low
₹89.5

Zim Laboratories Ltd(ZIMLAB) share price is ₹109.8. It is down -16.44% from its 52 Week High price of ₹131.4

Zim Laboratories Ltd(ZIMLAB) share price is ₹109.8. It is up 22.68% from its 52 Week Low price of ₹89.5

Zim Laboratories Ltd(ZIMLABReturns
1 Day Returns
0.09%
1 Month Returns
0.02%
3 Month Returns
-1.07%
1 Year Returns
-5.34%